Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Inventory (2024 - 2025)

Historic Inventory for Autolus Therapeutics (AUTL) over the last 2 years, with Q3 2025 value amounting to $27.7 million.

  • Autolus Therapeutics' Inventory changed N/A to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Autolus Therapeutics reported Inventory of $27.7 million as of Q3 2025.
  • In the past 5 years, Autolus Therapeutics' Inventory ranged from a high of $27.7 million in Q3 2025 and a low of $4.1 million during Q4 2024